Sprout Pharmaceuticals

Timeline

1. Dec 13, 2025 FDA FDA New indication / efficacy supplement: ADDYI (flibanserin) — NDA022526/13, Dec 13, 2025. Applicant at approval: Sprout Pharmaceuticals, Inc. source ↗

FDA records (last 2 years)

• Dec 13, 2025 FDA New indication / efficacy supplement: ADDYI (flibanserin) — NDA022526/13, Dec 13, 2025. Applicant at approval: Sprout Pharmaceuticals, Inc. source ↗